| Mrs Debbie Lee Crist, MS CCCSLP | |
|
115 South 4th St, Basin, WY 82410 | |
| (307) 568-2914 | |
| (307) 568-2914 |
| Full Name | Mrs Debbie Lee Crist |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 115 South 4th St, Basin, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508014382 | NPI | - | NPPES |
| 1770688871 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP428 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Debbie Lee Crist, MS CCCSLP Po Box 882, 115 South 4th St, Basin, WY 82410 Ph: (307) 568-2914 | Mrs Debbie Lee Crist, MS CCCSLP 115 South 4th St, Basin, WY 82410 Ph: (307) 568-2914 |
News Archive
Choosing a neighborhood that has places to walk to and safe routes to get there can help your child maintain a healthy weight during adolescence.
Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.
NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today the closing of its previously announced 5,000,000 share public offering and the exercise of the over-allotment option in full by the underwriters for an additional 750,000 shares of the Company's common stock, bringing the total shares offered to 5,750,000.
Palatin Technologies, Inc., a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential, today announced that it has started its bremelanotide pivotal registration program.
› Verified 6 days ago
Mrs. Stine Turgeon, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 South 4th St, Basin, WY 82410 Phone: 307-568-2914 |